Anders Göransson
Corporate Officer/Principal bij BACTIGUARD HOLDING AB
Vermogen: 119 306 $ op 31-03-2024
Profiel
Anders Göransson is currently working as EVP & Global Head-Licensing at Bactiguard AB and as Head-Licensing & Executive Vice President at Bactiguard Holding AB.
He has a Master's degree in Business Administration from Suffolk University and a graduate degree from the University of Uppsala.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
BACTIGUARD HOLDING AB
0.06% | 31-12-2022 | 17 620 ( 0.06% ) | 119 306 $ | 31-03-2024 |
Actieve functies van Anders Göransson
| Bedrijven | Functie | Begin |
|---|---|---|
| BACTIGUARD HOLDING AB | Corporate Officer/Principal | 21-05-2023 |
Bactiguard AB
 Bactiguard AB Medical DistributorsDistribution Services Bactiguard AB develops and supplies infection protection solutions to reduce the risk of hospital and healthcare related infections. Its product portfolio, Bactiguard Infection Protection, prevents bacterial adhesion and biofilm formation on medical devices. The firm's products include Infection Prevention Foley Catheter, Central Venous Catheter, and Endotracheal Tube. The company was founded by Nils Peder Christian Kinch on June 13, 2005 and is headquartered in Stockholm, Sweden. | Corporate Officer/Principal | 23-05-2023 |
Opleiding van Anders Göransson
| Suffolk University | Masters Business Admin |
| University of Uppsala | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| BACTIGUARD HOLDING AB | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Bactiguard AB
Bactiguard AB Medical DistributorsDistribution Services Bactiguard AB develops and supplies infection protection solutions to reduce the risk of hospital and healthcare related infections. Its product portfolio, Bactiguard Infection Protection, prevents bacterial adhesion and biofilm formation on medical devices. The firm's products include Infection Prevention Foley Catheter, Central Venous Catheter, and Endotracheal Tube. The company was founded by Nils Peder Christian Kinch on June 13, 2005 and is headquartered in Stockholm, Sweden. | Distribution Services |
